Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma.
Int J Mol Sci. 2022 Oct 21;23(20):12687. doi: 10.3390/ijms232012687.
Int J Mol Sci. 2022.
PMID: 36293545
Free PMC article.
Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH-DR5-B with Dual VEGFR2 and DR5 Receptor Specificity.
Yagolovich AV, Artykov AA, Isakova AA, Vorontsova YV, Dolgikh DA, Kirpichnikov MP, Gasparian ME.
Yagolovich AV, et al. Among authors: vorontsova yv.
Int J Mol Sci. 2022 May 24;23(11):5860. doi: 10.3390/ijms23115860.
Int J Mol Sci. 2022.
PMID: 35682540
Free PMC article.
Item in Clipboard
Application of an Autoinduction Strategy to Optimize the Heterologous Production of an Antitumor Bispecific Fusion Protein Based on the TRAIL Receptor-Selective Mutant Variant in Escherichia coli.
Isakova A, Artykov A, Vorontsova Y, Dolgikh D, Kirpichnikov M, Gasparian M, Yagolovich A.
Isakova A, et al.
Mol Biotechnol. 2023 Apr;65(4):581-589. doi: 10.1007/s12033-022-00561-6. Epub 2022 Sep 12.
Mol Biotechnol. 2023.
PMID: 36094644
Item in Clipboard
Cite
Cite